Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has provided an update.
Consun Pharmaceutical Group Ltd. has scheduled a board meeting for August 19, 2025, to discuss and approve the unaudited consolidated interim results for the first half of the year, consider the announcement of these results, and deliberate on the potential payment of an interim dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial health and strategic decisions, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, with its shares listed on the Hong Kong Stock Exchange.
Average Trading Volume: 2,553,556
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.23B
For detailed information about 1681 stock, go to TipRanks’ Stock Analysis page.